Systematic Financial Management LP bought a new stake in Ardent Health Partners, LLC (NYSE:ARDT - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The institutional investor bought 32,380 shares of the company's stock, valued at approximately $595,000.
Several other hedge funds have also bought and sold shares of the company. BNP Paribas Financial Markets bought a new position in Ardent Health Partners during the third quarter worth $42,000. Financial Management Professionals Inc. bought a new stake in shares of Ardent Health Partners during the 3rd quarter worth about $50,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners in the 3rd quarter valued at about $135,000. Quadrature Capital Ltd bought a new position in Ardent Health Partners in the 3rd quarter valued at about $229,000. Finally, Centiva Capital LP acquired a new stake in Ardent Health Partners during the third quarter worth approximately $469,000.
Ardent Health Partners Price Performance
Shares of NYSE:ARDT traded up $0.65 during midday trading on Friday, hitting $16.65. The stock had a trading volume of 282,817 shares, compared to its average volume of 232,256. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The stock has a 50-day moving average price of $17.58. Ardent Health Partners, LLC has a fifty-two week low of $14.57 and a fifty-two week high of $20.72.
Analyst Ratings Changes
Several research firms have recently commented on ARDT. JPMorgan Chase & Co. started coverage on Ardent Health Partners in a research report on Monday, August 12th. They issued a "neutral" rating and a $18.00 target price on the stock. Stephens reiterated an "overweight" rating and set a $24.00 price objective on shares of Ardent Health Partners in a research report on Thursday, September 19th. Mizuho began coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They issued an "outperform" rating and a $20.00 target price for the company. Bank of America lowered shares of Ardent Health Partners from a "buy" rating to a "neutral" rating and lowered their price target for the stock from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, Leerink Partners boosted their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the company an "outperform" rating in a report on Tuesday, November 12th. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $21.82.
Check Out Our Latest Research Report on ARDT
About Ardent Health Partners
(
Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Further Reading
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
